text.skipToContent text.skipToNavigation

qBiomarker PreAMP Synthesis Kit (12)

For preamplification prior to real-time PCR to support ultrasensitive cancer mutation detection
  • Nested preamplification improves sensitivity and decreases false positives
  • PCR-based protocol is accessible to most laboratories
  • Integrated, complimentary data analysis simplifies mutation calling
The qBiomarker PreAMP Synthesis Kit enables preamplification of DNA from up to 12 small or degraded DNA samples prior to analysis with qBiomarker Somatic Mutation PCR Arrays and Assays. The kit contains the components for qBiomarker PreAMP PCR Mastermix which, together with the qBiomarker PreAMP Mix, uses multiplex PCR-based preamplification to amplify loci-specific DNA target templates with minimal bias for analysis with the qBiomarker Somatic Mutation PCR Arrays or Assays.
Cat No./ID: 337032
qBiomarker PreAMP Synthesis Kit
€327.00
Add To Cart
For 12 samples: qBiomarker PreAMP Mastermix; Side Reaction Reducer; RNase-free water
Principle

For successful somatic mutation detection, experimental methods must detect the DNA molecules with mutations of interest in samples that may contain a vast excess of DNA molecules with the wildtype sequence at the same locus. Based off of this principle, there are two factors that affect these experiments: the inherent percentage of mutant DNA in a sample, and the sensitivity of the method. In the case of cancer, a specific mutation may be found in a small percentage of the tumor, which is a characteristic of tumor heterogeneity. Additionally, different types of samples and sample sources affect this ratio of mutant to wildtype DNA as well as the number of DNA molecules that can be assayed. A method’s sensitivity directly reflects how few mutant DNA molecules can be detected within a given amount of wildtype DNA.

Sample types common in cancer research, including formalin-fixed paraffin embedded (FFPE) samples, serum samples, fine needle biopsies, and sorted cells frequently contain only small amounts of amplifiable DNA. Genomic DNA in FFPE samples is fragmented, for example, while DNA in serum samples is heavily diluted. In the case of fine needle biopsies or sorted cells, these samples have small numbers of cells that will yield limited amounts of genomic DNA. Amplifying genomic DNA enables more accurate detection of the mutations in DNA from these sample types.

Procedure
DNA is first isolated from FFPE, serum, or small samples using the appropriate QIAamp or DNeasy kit. The qBiomarker PreAMP Synthesis Kit and a qBiomarker PreAMP Mix are then used to preamplify the DNA using locus-specific primers. qBiomarker Somatic Mutation Arrays or Assays are used for mutation detection, and CT values are uploaded into the GeneGlobe Data Analysis tool for data analysis and mutation calls.
Applications

The qBiomarker PreAMP Synthesis Kit is highly suited for preamplification of genomic DNA from samples with low amounts of amplifiable DNA for exclusive use with qBiomarker Somatic Mutation PCR Arrays and Assays. Recommended sample types include:

  • FFPE samples
  • Plasma, serum, urine, or other cell-free body fluids
  • Laser capture microdissection samples
  • Fine needle biopsies
  • FACS-sorted cells

You are not authorized to download the resource

Handbooks & Protocols (2)
For screening disease-focused mutation panels by PCR
Show details
For real-time PCR-based, pathway- or disease-focused, somatic mutation profiling
Show details
Instrument Technical Documents (1)
For screening disease-focused mutation panels by PCR
Show details
Kit Handbooks (1)
For real-time PCR-based, pathway- or disease-focused, somatic mutation profiling
Show details
fragment fix placeholder

Customers who bought these products also bought